Achieving an organizational framework by implementing confirmatory preclinical research through ‘team science’ and by providing novel instruments for advanced experimental designs to increase validity.

Establishing and implement guidelines for preclinical trials of new treatments to maximize the success of clinical translation.

Focusing experimental stroke research on identification of new treatable targets with high translational potential that lead to successful clinical trials by 2030.